Evidence map›Paper›PMID 41000621›Full record

ArticlebioRxiv : the preprint server for biology2025

The Impact of Formic Acid Treatment on Brain Tissues for Prion Inactivation.

Dalia Shaaban, Alyssa Seerley, Lilia Crew, Clairissa Kaylor, Sayre McElroy, Emma Guter, June Pounder, Andrea Grindeland Panter

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Dalia ShaabanTouro University College of Osteopathic Medicine Montana, Great Falls, MT, United States.
Alyssa SeerleyWeissman Hood Institute at Touro University; McLaughlin Research Institute, Great Falls, MT, United States.ORCID 0009-0009-6569-3833
Lilia CrewTouro University College of Osteopathic Medicine Montana, Great Falls, MT, United States.
Clairissa KaylorTouro University College of Osteopathic Medicine Montana, Great Falls, MT, United States.
Sayre McElroyWeissman Hood Institute at Touro University; McLaughlin Research Institute, Great Falls, MT, United States.
Emma GuterWeissman Hood Institute at Touro University; McLaughlin Research Institute, Great Falls, MT, United States.
June PounderWeissman Hood Institute at Touro University; McLaughlin Research Institute, Great Falls, MT, United States.
Andrea Grindeland PanterTouro University College of Osteopathic Medicine Montana, Great Falls, MT, United States.ORCID 0009-0001-7862-816X

Funding

Modulation of Exosome Release for Functional Restoration in Age-related Retinal DisordersP20GM152335 · NIGMS · MC LAUGHLIN RESEARCH INSTITUTE · PI Renee A Reijo Pera · 2024 to 2026
$11.1M
NIGMS NIH HHS P20 GM152335
6 · The paper itself

Abstract

There are significant risks in clinical, diagnostic, and research settings to those who investigate prion diseases, due to the difficult nature of inactivating prion proteins with standard decontamination methods. Formic acid treatment has been shown to be effective for decontaminating infectious prions and commonly used in biosafety practice to prevent occupational exposure. However, the impact of formic acid protocols on the morphology of tissue samples has not been adequately documented. The goal of this study is to examine morphologic effects of formic acid treatment on central nervous system tissue, using mouse model brain hemisphere tissues that exhibit varying degrees of neurodegeneration as a model. This study included normal, non-diseased wild-type tissues and a 5xFAD model, which recapitulates aspects of Alzheimer's Disease (AD). A model exhibiting Chronic Wasting Disease (CWD), a prion disease of deer and elk, was also used to analyze the effects of formic acid on tissues with spongiform changes. Tissues from both formic acid and untreated control treatment groups were embedded in paraffin, sectioned, stained, and imaged microscopically. Anatomical regions were analyzed and evaluated quantitatively to determine the width, area, and structural integrity of the tissue between treatment groups. Our findings demonstrated that while formic acid has been previously reported to effectively inactivate prions, it compromised the morphology of mouse brain tissues. Furthermore, the effects of formic acid were not distributed equally between regions of the brain. Age did not play a role in the morphologic changes seen in the formic acid treatment group. Interestingly, the presence of neurodegeneration in the tissues did not appear to exacerbate the effects of morphological changes post-formic acid treatment. These results emphasize the need to explore alternative prion inactivation methods that ensure the safety and reliability of handling prion-infected tissues without compromising the integrity of tissues.

Identifiers

PMID41000621
PMCPMC12458212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.